| Anticancer Fund

PropAngio study protocol: a neoadjuvant trial on the efficacy of propranolol monotherapy in cutaneous angiosarcoma—a proof of principle study

Heinhuis KM, IJzerman NS, Koenen AM, et al.

Fri, 09/18/2020 - 12:00

Comprehensive book on drug repurposing and cancer therapy

Tue, 09/15/2020 - 12:00

Pancreatic resection with perioperative drug repurposing of propranolol and etodolac: trial protocol of the phase-II randomised placebo controlled PROSPER trial

Felix J Hüttner, Ilse Rooman, Gauthier Bouche, Phillip Knebel, Johannes Hüsing, André L Mihaljevic, Thilo Hackert, Oliver Strobel, Markus W Büchler, Markus K Diener. Pancreatic resection with perioperative drug repurposing of propranolol and etodolac: trial protocol of the phase-II randomised placebo controlled PROSPER trial. BMJ Journals, 2020 Sep 30;10(9):e040406, doi: 10.1136/bmjopen-2020-040406.

Fri, 08/28/2020 - 12:00

Predicting combinations of immunomodulators to enhance dendritic cell-based vaccination based on a hybrid experimental and computational platform

Rita Ahmed, Isaac Crespo, Sandra Tuyaerts, Amel Bekkar, Michele Graciotti, Ioannis Xenarios, Lana E. Kandalaft (2020). Predicting combinations of immunomodulators to enhance dendritic cell-based vaccination based on a hybrid experimental and computational platform. Computational and Structural Biotechnology Journal 18 (2020) 2217–2227, https://doi.org/10.1016/j.csbj.2020.08.001

Sat, 08/08/2020 - 12:00

"Strengthening Europe in the fight against cancer"

Tue, 08/04/2020 - 12:00

Repurposing of drugs for triple negative breast cancer: an overview

Andrea Spini, Sandra Donnini, Pan Pantziarka, Sergio Crispino, Marina Ziche (2020). Repurposing of drugs for triple negative breast cancer: an overview. eCancer 13 July 2020, https://doi.org/10.3332/ecancer.2020.1071

Tue, 07/14/2020 - 12:00

Reflection on Europe's Cancer Mission Board

Fri, 07/10/2020 - 12:00

Our response to the European Commission's public consultation on the Pharmaceutical Strategy Roadmap

Tue, 07/07/2020 - 12:00